The invention claims the use of Repirinast, either alone or in combination with telmisartan, for the treatment or prophylaxis of renal fibrosis or kidney disease. The base claims of the patent ...

Detailed price information for Algernon Pharmaceuticalsinc (AGN-CN) from The Globe and Mail including charting and trades.